Prof. Chris Packard (Glasgow) reviews the potential implications of new LDL-c lowering clinical trial outcomes for ezetimibe and new therapeutic options such as PCSK9 inhibitors

View  Slides • 8-9-2014

LDL-c lowering by statins & cholesterol absorption inhibitors: Do we need anything new?

Presentation by prof. Chris Packard during the PACE 2014 SNAPSHOT session on August 30, 2014 in Barcelona